URGENT: FDA Opens Comments for COVID-19 Jab for Babies and Toddlers Ahead of Vaccine Advisory Committee Meeting

The Food and Drug Administration’s ‘Vaccines and Related Biological Products Advisory Committee’ will meet on June 14th and 15th to review the COVID-19 shot for children between the ages of six months and five years.

The agency has opened the site for comments.

Comments received on or before June 7th will be provided to the committee.

Comments received after June 7th and by June 13th will be taken into consideration by the FDA.

At the time of writing, the site has 5,119 comments.

They have opened up the site for comments about the #covidvaccine
& trying to put it on the childhood schedule. Once it’s on there they are completely protected from any liability
These Monsters Must Be Stopped !!https://t.co/fbhdNqFmPO

— Koziswellness (@koziswellness) June 5, 2022

You can write a comment to the FDA HERE.

regulations.gov explained where to access the online web conference:

Electronic Submissions

Submit electronic comments in the following way:

• Federal eRulemaking Portal: https://www.regulations.gov . Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov .

• If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see “Written/Paper Submissions” and “Instructions”).

Written/Paper Submissions

Submit written/paper submissions as follows:

• Mail/Hand Delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

• For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in “Instructions.”

Instructions: All submissions received must include the Docket No. FDA-2022-N-0904 for “Vaccines and Related Biological Products; Notice of Meeting; Establishment of a Public Docket; Request for Comments.” Received comments, those filed in a timely manner (see ADDRESSES ), will be placed in the docket and, except for those submitted as “Confidential Submissions,” publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday, 240-402-7500.